Women’s Board

The University of Chicago Cancer Research Foundation (UCCRF) is a private, not-for-profit organization that seeks funds to underwrite basic and clinical research programs on the causes, diagnosis, treatment and prevention of cancer at The University of Chicago Comprehensive Cancer Center. It was founded by philanthropist Maurice Goldblatt and since its creation has raised over $80 million for cancer research.

At the core of the Foundation’s efforts is the Women’s Board, founded by the late Mrs. Walter B. Wolfe in 1947. Since its creation, the Women’s Board has allocated over $19 million in funding. For the Board’s allocation history please click here.

The hallmark of the Women’s Board is that we fund the most innovative experimentation, enabling UChicago scientists to pursue promising avenues of investigation that would otherwise remain unexplored. The Board has been instrumental in launching some of the Center’s most successful and innovative programs, partnering with UChicago when they:

  • First explored the interactions between the immune system and malignant tumors and enlisted the body’s own resources in the fight against cancer.
  • Developed one of the world’s foremost programs in cancer genetics and the study, at the molecular level, of the structures, functions and interactions of proteins that can cause or inhibit the development and growth of malignancies.
  • Established global leadership in integrating genetics and drug therapy to create effective treatments accommodating the unique needs of individual patients.

The Women’s Board raises funds through three main efforts:

The Breakthrough Ball, one of Chicago’s premier social events, is a black tie dinner dance attended by nearly 500 guests who come to bid on a fabulous array of merchandise. This year, the gala will celebrate the 53rd event on November 9, 2019 at the Four Seasons Hotel Chicago. For more information about the auction, please click here.

The Annual Appeal, initiated in 1997, has netted over $2 million. To make a donation to the appeal, please click here.